Sub menu

FutureLab NMN 250 mg (526339)

ARTG ID 526339

ARTG Name
FutureLab NMN 250 mg
Product name
FutureLab NMN 250 mg
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicines
Sponsor
Melrose Laboratories Pty Ltd
Ingredients
nicotinamide mononucleotide
Licence category
LI
Licence status
A
Summary
Download: FutureLab NMN 250 mg(526339)-Summary-[PDF]

Related information

  • FutureLab NMN 250 mg (2025-26)

    2025-26
    Annual charge exemption
    Exempt from annual charge in 2025-26 due to Melrose Laboratories Pty Ltd declaring $0 turnover in that period.